The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science. Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs. 

Our pipeline programs range from cancer to infectious diseases and from discovery to early clinical trial stages, all aimed at preventing disease and healing humans around the world. 

We bring together leaders in research, drug development, and business to answer important biological questions and develop new interventions to treat, cure, and prevent disease. Our infrastructure and expertise extend from high-throughput screening and protein engineering to pharmacology and clinical development. 

Calibr’s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 100 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr’s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal, or foundation partnerships.

Life Sciences

Calibr at Scripps Research

Peter Schultz

Mary Sullivan

Vadim Klyushnichenko

Chan Beals

Clara A.

The Research and Development team at Calibr at Scripps Research plays a pivotal role in the drug discovery process, bridging scientific exploration with clinical application. This interdisciplinary team, comprising experts in medicinal chemistry, clinical operations, and compound management, focuses on identifying and optimizing new therapeutic compounds aimed at treating various diseases. By leveraging state-of-the-art facilities and cutting-edge technologies, the team drives projects from initial discovery through to early-stage clinical trials, ensuring that innovative solutions are developed to meet pressing medical needs.

Research and Development

About

Team members

Other teams at Calibr at Scripps Research

Leadership Team